Clinical Study of GT201 in the Treatment of Advanced Gynecological Tumors (Advanced Cervical Cancer)
NCT06191900 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4
Last updated 2026-04-27
Summary
This study is an early exploration clinical study with one arm.
The study consists of two stages, namely the dose escalation stage and the dose extension stage:
Conditions
- Adult
- Gynecological Tumors
Interventions
- BIOLOGICAL
-
Autologous tumor infiltrating lymphocyte injection（GT201）
GT201 treatment for advanced gynecological tumors (advanced cervical cancer)
Sponsors & Collaborators
-
Grit Biotechnology
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-06-05
- Primary Completion
- 2025-12-30
- Completion
- 2025-12-30
Countries
- China
Study Locations
More Related Trials
-
Autologous Tumor-Infiltrating Lymphocyte Injection(GT201) for Treatment of Patients With Advanced Lung Cancer
NCT06519669 ·Status: TERMINATED ·Phase: NA
-
GT101 Injection in the Treatment of Metastatic/Recurrent Advanced Solid Tumors
NCT06077903 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Clinical Study of Autologous Tumor-infiltrating Lymphocyte Injection (GT201) for Advanced Solid Tumors
NCT05729399 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Autologous Tumor-infiltrating Lymphocyte Injection (GT201) for the Treatment of Metastatic/Recurrent Advanced Solid Tumors
NCT05430360 ·Status: TERMINATED ·Phase: PHASE1
-
Exploratory Clinical Study of Autologous Tumor-infiltrating Lymphocyte Injection (GT201) for Advanced Gynecologic Tumors
NCT05724732 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
GT201 Injection in Combination With Teraplizumab Injection for Treatment of Patients With Non-small Cell Lung Cancer
NCT06235242 ·Status: TERMINATED ·Phase: NA
-
A Clinical Research About CD70-positive Advanced/Metastatic Solid Tumors Treated by CD70-targeted CAR-T
NCT05468190 ·Status: UNKNOWN ·Phase: PHASE1
-
Study of Anti-5T4 CAR-NK Cell Therapy in Advanced Solid Tumors
NCT05194709 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
A Study of GC201 TIL in Advanced Gynecologic Tumors (10hospital)
NCT05098171 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Prevention and Treatment of CINV Caused by TC Regimen in Gynecological Malignant Tumor Patients
NCT06007586 ·Status: COMPLETED ·Phase: PHASE3
-
Study of GV20-0251 in Participants With Solid Tumor Malignancies
NCT07070518 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Study of ZGGS18 in Combination With ZG005 in Patients With Advanced Solid Tumors
NCT06938880 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Clinical Research About CD70-targeted CAR-NKT Cells Therapy in Subjects with Advanced Malignant Solid Tumors
NCT06728189 ·Status: RECRUITING ·Phase: PHASE1
-
A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors
NCT06010875 ·Status: RECRUITING ·Phase: PHASE1
-
RT201(Tumor Antigen-specific Macrophage Tumor Vaccine)
NCT05930301 ·Status: UNKNOWN
-
A Single-Arm, Open-Label, Phase I Study of GK01 for Advanced Solid Tumor
NCT06954558 ·Status: RECRUITING ·Phase: PHASE1
-
CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors
NCT07181720 ·Status: RECRUITING ·Phase: PHASE1
-
A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors
NCT05420545 ·Status: UNKNOWN ·Phase: PHASE1
-
Safety and Efficacy Evaluation of 4th Generation Safety-engineered CAR T Cells Targeting Sarcomas
NCT03356782 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Study of GC203 TIL in Advanced Solid Tumors (NF)
NCT07256756 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
A Study of GNC-035, a Tetra-specific Antibody, in Participants With Locally Advanced or Metastatic Solid Tumors
NCT05039931 ·Status: WITHDRAWN ·Phase: PHASE1
-
CRTE7A2-01 TCR-T Cell for HPV-16 Positive Advanced Cervical, Anal, or Head and Neck Cancers
NCT05122221 ·Status: UNKNOWN ·Phase: PHASE1
-
A Phase I Study to Investigate the Safety and Tolerability of KGX101 Monotherapy and Combination Therapy With Envafolimab in Advanced or Metastatic Solid Tumor Patients
NCT07260305 ·Status: RECRUITING ·Phase: PHASE1
-
Study of ZGGS18 in Patients With Advanced Solid Tumors
NCT05584800 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Pharmacokinetics and Tolerancebility Studies of Gentuximab Injection in the Treatment ofPatients With Late Recurrence of Metastatic Solid Tumors in China
NCT03313219 ·Status: UNKNOWN ·Phase: PHASE1